By MahWengKwai & Associates Sports Law Practice Group
A Japanese athlete has been implicated for doping at The Pyeongchang 2018 Winter Olympics. Speed Skater Kei Saito tested positive for acetazolamide, when his pre-competition sample was taken. Acetazolamide is a substance that is prohibited at all times by the World Anti Doping Agency (WADA). Saito was schedules to compete in the second heat of the men’s 5000m relay for the first time.
Saito claimed that consults medical experts to treat any of his injuries and has been very careful with what he consumes and cannot possibly think of a moment where he may have accidentally taken the prohibited substance.
However, the Court of Arbitration for Sport (CAS) said that Saito voluntarily accepted his provisional suspension. Pursuant to Article 10.11.3.2 of the World Anti Doping Code (WADA Code), the athlete shall receive credit for such period of voluntarily suspension against any period of ineligibility which may ultimately be imposed.